Oversea drug trials exploit and kill Third World poor and US consumers alike

(The Best Years in Life) Over the past two decades, drug makers have increasingly shifted trials for drugs intended for the U.S. market to Third World countries where it is easier and cheaper to recruit trial patients and where oversight is minimal. While outsourcing drug trials may save significant money for the pharmaceutical companies, the cost in human lives and suffering for both the Third World trial participants and American drug users is likely horrendous.

For the rest of the article click Here.